DUBLIN--(BUSINESS WIRE)--The "Europe External Urine Management Products Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Offline and Online), By Product, By End- use (Hospitals, Clinics, Home Care Settings), By Country and Growth Forecast, 2022 - 2028" report has been added to ResearchAndMarkets.com's offering.
The Europe External Urine Management Products Market is expected to witness market growth of 4.8% CAGR during the forecast period (2022-2028).
Urinary incontinence and insufficient bladder emptying are managed with the use of internally and externally urinary catheters. The source of the bladder malfunction determines whether a short- or long-term catheterization is necessary and whether an implantable, periodic, or external catheter should be used as a result. Depending on the fundamental bladder ailment, treatment objectives, and gender appropriateness, the catheterization technique is chosen.
When using an indwelling catheter, the duration of the catheter should be as short as possible to ensure patient safety and comfort. It is important to recognize that complications like infection and its sequelae are directly related to catheter use for a long period. In order complications, some more recent catheter systems have coatings. The most common complications related to indwelling catheters are encrustations, urethral trauma and erosion, bladder stones, and bladder cancer, as well as epididymitis in men.
Urine incontinence (UI) and urinary retention are the two main bladder dysfunctions that are treated using catheters (UR). Urinary incontinence is the unintentional loss of urine and can be categorized as either stress incontinence (urinary leakage with activity or effort, such as coughing, laughing, or overflowing) or urgency incontinence (urine loss following immediacy and associated with overactive bladder illnesses of urgency and frequency).
There are now half a million people in the UK who are 90 years or older, more than twice as many as there were in 1985 due to an increase in the average life expectancy over the past few decades. By 2035, it's expected that more than half of British inhabitants is expected to be 50 or older. However, there hasn't been a corresponding rise in life expectancy to go along with these gains. The difference in average longevity between England's poorest and richest regions has substantially increased during the past few years. From 9.0 years in 2011 to 2013 to 9.4 years in 2017 and 2019, it increased for males.
The Germany market dominated the Europe External Urine Management Products Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $48 million by 2028. The UK market is anticipated to grow at a CAGR of 3.9% during (2022 - 2028). Additionally, The France market is expected to display a CAGR of 5.6% during (2022 - 2028).
Scope of the StudyMarket Segments Covered in the Report:By Distribution Channel
- Offline
- Online
By Product
- Male External Catheters
- Female External Catheters
- Urine Collection Accessories
By End Use
- Hospitals
- Clinics
- Home Care Settings
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
- Becton, Dickinson and Company
- B. Braun Melsungen AG
- Sage Products LLC (Stryker Corporation)
- Teleflex, Inc.
- Cardinal Health, Inc.
- Consure Medical
- Hollister, Inc.
- Coloplast Group
- Tilla Care Ltd.
- Sterimed Group
Key Topics Covered:
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Europe External Urine Management Products Market by Distribution Channel
Chapter 4. Europe External Urine Management Products Market by Product
Chapter 5. Europe External Urine Management Products Market by End-use
Chapter 6. Europe External Urine Management Products Market by Country
Chapter 7. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/u7ylkt
